CD19 and chronic obstructive pulmonary disease: The population of different lymphocytes as CD4+, CD8+, and CD19+ was increased in the CS-induced COPD group (63.85%, 70.68%, and 56.82%, respectively) compared with the control (19.98%, 18.22%, and 12.60%).